PTH and osteoporosis: Given that injections of PTH is approved for the treatment of osteoporosis, it has been suggested that short acting calcilytics, causing bursts of PTH levels similar to the injected PTH rather than the sustained increases seen with NPS 2143, could lead to increases in BMD [29, 53].